These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of primary biliary cirrhosis: from diagnosis to end-stage disease. Lazaridis KN; Lindor KD Curr Gastroenterol Rep; 2000 Apr; 2(2):94-8. PubMed ID: 10981009 [TBL] [Abstract][Full Text] [Related]
3. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Heathcote EJ Hepatology; 2000 Apr; 31(4):1005-13. PubMed ID: 10733559 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of primary biliary cirrhosis. Ali AH; Carey EJ; Lindor KD Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237 [TBL] [Abstract][Full Text] [Related]
5. Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy? Fennerty MB Postgrad Med; 1993 Nov; 94(6):81-8; 92. PubMed ID: 8234100 [TBL] [Abstract][Full Text] [Related]
6. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis. Burman BE; Jhaveri MA; Kowdley KV Clin Liver Dis; 2017 Nov; 21(4):709-723. PubMed ID: 28987258 [TBL] [Abstract][Full Text] [Related]
7. [Primary biliary cirrhosis]. Kuiper EM; den Ouden-Muller JW; van Buuren HR Ned Tijdschr Geneeskd; 2009; 153():A483. PubMed ID: 19900324 [TBL] [Abstract][Full Text] [Related]
8. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Babatin MA; Sanai FM; Swain MG Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885 [TBL] [Abstract][Full Text] [Related]
9. Clinical features and management of primary biliary cirrhosis. Crosignani A; Battezzati PM; Invernizzi P; Selmi C; Prina E; Podda M World J Gastroenterol; 2008 Jun; 14(21):3313-27. PubMed ID: 18528929 [TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis. Verma A; Maxwell JD; Ang L; Davis T; Hodges S; Northfield TC; Zaidi M; Pazianas M Osteoporos Int; 2002 Aug; 13(8):677-82. PubMed ID: 12181628 [TBL] [Abstract][Full Text] [Related]
12. Review article: pathophysiology and management of primary biliary cholangitis. Leung KK; Deeb M; Hirschfield GM Aliment Pharmacol Ther; 2020 Oct; 52(7):1150-1164. PubMed ID: 32813299 [TBL] [Abstract][Full Text] [Related]
13. [Research advances in primary biliary cholangitis]. Duan WJ; Jia JD Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):801-804. PubMed ID: 29325271 [TBL] [Abstract][Full Text] [Related]
14. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Kaplan MM Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200 [TBL] [Abstract][Full Text] [Related]
15. Treatment of primary biliary cirrhosis. Poupon R; Poupon RE Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):615-28. PubMed ID: 10976018 [TBL] [Abstract][Full Text] [Related]